HCA Healthcare Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Earnings and Financial Performance - HCA Healthcare is expected to report quarterly earnings of $6 14 per share for Q4 2025, up from $5 90 per share in the same period last year [1] - The company projects revenue of $18 23 billion for the recent quarter, compared to $17 3 billion a year earlier [1] Stock Performance and Analyst Ratings - HCA Healthcare shares gained 1 8% to close at $325 36 on Thursday [3] - Truist Securities analyst David Macdonald maintained a Buy rating but cut the price target from $430 to $390 [5] - Raymond James analyst John Ransom downgraded the stock from Outperform to Market Perform [5] - Keybanc analyst Matthew Gillmor maintained an Overweight rating but cut the price target from $475 to $420 [5] - Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating and raised the price target from $390 to $400 [5] - Deutsche Bank analyst Pito Chickering maintained a Buy rating and raised the price target from $359 to $375 [5] Leadership Changes - HCA Healthcare named Wendy Warren as Senior Vice President and Chief Ethics and Compliance Officer on Dec 20, 2024 [2]